Bruker (BRKR) Competitors

Revvity (NYSE:PKI) and Bruker (NASDAQ:BRKR) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Is PKI or BRKR a better dividend stock?

Revvity pays an annual dividend of $0.28 per share. Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.4%. Revvity pays out 3.6% of its earnings in the form of a dividend. Bruker pays out 9.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Does the media favor PKI or BRKR?

In the previous week, Bruker had 10 more articles in the media than Revvity. MarketBeat recorded 10 mentions for Bruker and 0 mentions for Revvity. Revvity's average media sentiment score of 0.73 beat Bruker's score of 0.17 indicating that Revvity is being referred to more favorably in the media.

Company	Overall Sentiment
Revvity	Positive
Bruker	Neutral

Which has more risk & volatility, PKI or BRKR?

Revvity has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500.

Does the MarketBeat Community prefer PKI or BRKR?

Bruker received 174 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 64.81% of users gave Bruker an outperform vote while only 58.75% of users gave Revvity an outperform vote.

Company	Underperform	Outperform
Revvity	Outperform Votes 500 58.75%	Underperform Votes 351 41.25%
Bruker	Outperform Votes 674 64.81%	Underperform Votes 366 35.19%

Do insiders & institutionals believe in PKI or BRKR?

85.2% of Revvity shares are held by institutional investors. Comparatively, 79.5% of Bruker shares are held by institutional investors. 0.5% of Revvity shares are held by company insiders. Comparatively, 28.3% of Bruker shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Which has better valuation and earnings, PKI or BRKR?

Revvity has higher revenue and earnings than Bruker. Revvity is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revvity	$3.31B	0.00	$569.18M	$7.68	N/A
Bruker	$2.96B	2.62	$427.20M	$2.08	24.66

Is PKI or BRKR more profitable?

Revvity has a net margin of 28.94% compared to Bruker's net margin of 9.41%. Bruker's return on equity of 21.52% beat Revvity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Revvity	28.94%	11.17%	5.83%
Bruker	9.41%	21.52%	6.69%

Do analysts recommend PKI or BRKR?

Bruker has a consensus price target of $79.36, indicating a potential upside of 54.70%. Given Bruker's stronger consensus rating and higher probable upside, analysts clearly believe Bruker is more favorable than Revvity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revvity	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bruker	1 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.55

Summary

Bruker beats Revvity on 12 of the 19 factors compared between the two stocks.